Belvedere Trading’s Direxion Daily Pharmaceutical & Medical Bull 3X ETF PILL Stock Holding History

Belvedere Trading’s Portfolio PILL Stock Details PILL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-10,030	Closed	-$72.4K	–	947
2025 Q1	$72.4K	Buy	+10,030	New	+$75.1K	﹤0.01%	459

Other funds holding PILL

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

GTS Securities New York $2.83B AUM 21.76% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Belvedere Trading's PILL Position: Q2 2025 in Review

Belvedere Trading sold out of Direxion Daily Pharmaceutical & Medical Bull 3X ETF (PILL) in Q2 2025, closing a stake of 10,030 shares — an estimated $72.4K sold.

Belvedere Trading first reported a position in PILL in Q1 2025 and held it in 1 quarter. The position peaked at $72.4K in Q1 2025. 5 funds tracked by Wall St. Rank hold PILL as of Q2 2025.

Belvedere Trading reported no remaining Direxion Daily Pharmaceutical & Medical Bull 3X ETF position as of Q2 2025 after selling out during the quarter.
Belvedere Trading sold 10,030 Direxion Daily Pharmaceutical & Medical Bull 3X ETF shares in Q2 2025, an estimated $72.4K.
Belvedere Trading first reported a position in Direxion Daily Pharmaceutical & Medical Bull 3X ETF in Q1 2025 and held it in 1 quarter.
Belvedere Trading's Direxion Daily Pharmaceutical & Medical Bull 3X ETF position peaked at $72.4K in Q1 2025.
5 funds tracked by Wall St. Rank held Direxion Daily Pharmaceutical & Medical Bull 3X ETF as of Q2 2025.

Based on Belvedere Trading's 13F filing for Q2 2025, filed 1 Aug 2025.